The Carlyle Group completed an investment in Knack RCM – a Woodbridge, New Jersey-based provider of tech-enabled, end-to-end revenue cycle management services – in Q4 2025. No press announcement was issued by either party. Healthcare Dealflow confirmed the close via Carlyle’s Q4 2025 earnings filing with the SEC, which listed Knack RCM as notable capital deployed during the quarter (Carlyle Q4 2025 8-K).
The transaction had been reported as signed in August 2025, with the Economic Times citing people aware of the matter that Carlyle had agreed to acquire a significant majority stake at a valuation of approximately $500 million.
Knack RCM serves a broad range of healthcare providers including independent and multispecialty practices, ambulatory surgical centers, durable medical equipment suppliers, and hospital systems, offering billing, coding, accounts receivable management, and AI-driven workflow automation.
Healthcare Dealflow’s The Daily Brief delivers healthcare deal activity, news, and analysis to your inbox every business day. Join the investment banks, private equity firms, and advisors who rely on it to stay current. Subscribe to The Daily Brief →